AzTrials
AzTrials

Frail Elderly SyndromeNCT05940779

Relationship Between the Risk of Falls and Frailty, and the Effect of a Physical Exercise Program on These Conditions in the Elderly: a Randomized Crossover Clinical Trial.

A study testing Therapeutic exercise program in people with Frail Elderly Syndrome and Fall, run by University of Valencia at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this randomized crossover clinical trial is to examine the effectiveness of a new therapeutic exercise program in elderly patients with risk of falls and physical fragility. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Frail Elderly Syndrome, Fall
What is being tested?
Therapeutic exercise program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSpain
Study dates
22 Sep 2021to 30 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Community dwelling older adults.
  • Independent for ambulation.
  • With a cognitive state that do not prevent understand the researcher indications.
  • Not performing regular physical exercise (only basic activities of daily living, but no other type of intervention).

Who cannot join

  • Contraindication of physical exercise.
  • Evident impaired cognitive state.
  • Vestibular or central nervous system affection.
  • Can´t speak and understand spanish correctly.

Trial locations and contacts

1 site in 1 country.

Belén Quel Tejón contact

675760137

bequelte@gmail.com

José María Blasco Igual contact

963983855

Jose.Maria.Blasco@uv.es

Spain1 site, 1 recruiting
  • University of Valencia

    Valencia, 46010

    José María Blasco Igual, 963983855, Jose.Maria.Blasco@uv.es

    Recruiting

Other trials in Spain

About this study

The goal of this randomized crossover clinical trial is to examine the effectiveness of a new therapeutic exercise program in elderly patients with risk of falls and physical fragility. The main questions it aims to answer are:

  • If the therapeutic exercise program proposed is a successful treatment for this kind of patients
  • If patients at risk of falls also suffer from pre-frailty or frailty, and if they can be treated together with the proposed therapy.
Read more

Participants will follow a program consisting of exercises to correct posture, gain strength and contribute to greater balance.

Researchers will compare the therapy and control groups to see if the program increases the percentage of muscle mass of participants, their mobility, balance, quality of life and if they reduce their Fried´s frailty criteria, fear of falling and falls compared to their usual physical activity.

Being tested
Therapeutic exercise program

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Therapeutic exercise programOther

    The intervention is a therapeutic program composed of self-resisted strength exercises, balance training and exercises to improve posture.

Study groups in NCT05940779
Study groupRoleWhat they receive
Exercise groupExperimentalNot described
Receives: Other: Therapeutic exercise program
Control groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timed Up and Go (TUG)

    Measured: Assessed before the first intervention (baseline).

  2. Timed Up and Go (TUG)

    Measured: Assessed after the first intervention (3 months later).

  3. Timed Up and Go (TUG)

    Measured: Assessed after the second intervention (3 months after the previous assessement).

  4. Timed Up and Go (TUG)

    Measured: Assessed after 3 months from the previous assessement.

  5. Fried frailty criteria

    The Fried frailty criteria are five: unintentional weight loss, muscular weakness, low resistance or tiredness, slow gait and low level of physical activity.

    Measured: Assessed before the first intervention (baseline).

  6. Fried frailty criteria

    The Fried frailty criteria are five: unintentional weight loss, muscular weakness, low resistance or tiredness, slow gait and low level of physical activity.

    Measured: Assessed after the first intervention (3 months later).

  7. Fried frailty criteria

    The Fried frailty criteria are five: unintentional weight loss, muscular weakness, low resistance or tiredness, slow gait and low level of physical activity.

    Measured: Assessed after the second intervention (3 months after the previous assessement).

  8. Fried frailty criteria

    The Fried frailty criteria are five: unintentional weight loss, muscular weakness, low resistance or tiredness, slow gait and low level of physical activity.

    Measured: Assessed after 3 months from the previous assessement.

Secondary outcomes (18)
  1. Falls and their consequences

    The number of falls in the last year will be asked.

    Measured: Assessed before the first intervention (baseline).

  2. Falls and their consequences

    A follow-up made with phone calls.

    Measured: Every two weeks from date of the first assessement until the date of the study completion, an average of 1 year.

  3. Berg Balance Scale (BBS)

    From 0 to 56. It shows a better balance when the score is higher.

    Measured: Assessed before the first intervention (baseline).

  4. Berg Balance Scale (BBS)

    From 0 to 56. It shows a better balance when the score is higher.

    Measured: Assessed after the first intervention (3 months later).

  5. Berg Balance Scale (BBS)

    From 0 to 56. It shows a better balance when the score is higher.

    Measured: Assessed after the second intervention (3 months after the previous assessement).

  6. Berg Balance Scale (BBS)

    From 0 to 56. It shows a better balance when the score is higher.

    Measured: Assessed after 3 months from the previous assessement.

  7. Falls Efficacy Scale-International (FES-I)

    From 16 to 64. Higher scores show more concern of falling.

    Measured: Assessed before the first intervention (baseline).

  8. Falls Efficacy Scale-International (FES-I)

    From 16 to 64. Higher scores show more concern of falling.

    Measured: Assessed after the first intervention (3 months later).

  9. Falls Efficacy Scale-International (FES-I)

    From 16 to 64. Higher scores show more concern of falling.

    Measured: Assessed after the second intervention (3 months after the previous assessement).

  10. Falls Efficacy Scale-International (FES-I)

    From 16 to 64. Higher scores show more concern of falling.

    Measured: Assessed after 3 months from the previous assessement.

  11. European Quality of Life-5 Dimensions (EuroQol-5D)

    It has two parts:

    The first one consists of questions about quality of life with scores from 0 to 1, higher if the quality of life of the patient is higher too.

    The second one is a visual analogic scale (VAS) from 0 (worst quality of life) to 100 (bes quality of life).

    Measured: Assessed before the first intervention (baseline).

  12. European Quality of Life-5 Dimensions (EuroQol-5D)

    It has two parts:

    The first one consists of questions about quality of life with scores from 0 to 1, higher if the quality of life of the patient is higher too.

    The second one is a visual analogic scale (VAS) from 0 (worst quality of life) to 100 (bes quality of life).

    Measured: Assessed after the first intervention (3 months later).

  13. European Quality of Life-5 Dimensions (EuroQol-5D)

    It has two parts:

    The first one consists of questions about quality of life with scores from 0 to 1, higher if the quality of life of the patient is higher too.

    The second one is a visual analogic scale (VAS) from 0 (worst quality of life) to 100 (bes quality of life).

    Measured: Assessed after the second intervention (3 months after the previous assessement).

  14. European Quality of Life-5 Dimensions (EuroQol-5D)

    It has two parts:

    The first one consists of questions about quality of life with scores from 0 to 1, higher if the quality of life of the patient is higher too.

    The second one is a visual analogic scale (VAS) from 0 (worst quality of life) to 100 (bes quality of life).

    Measured: Assessed after 3 months from the previous assessement.

  15. Muscle mass

    Assessed with and impedance scale.

    Measured: Assessed before the first intervention (baseline).

  16. Muscle mass

    Assessed with and impedance scale.

    Measured: Assessed after the first intervention (3 months later).

  17. Muscle mass

    Assessed with and impedance scale.

    Measured: Assessed after the second intervention (3 months after the previous assessement).

  18. Muscle mass

    Assessed with and impedance scale.

    Measured: Assessed after 3 months from the previous assessement.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2023
  2. Study start22 Sep 2021
  3. Primary completion30 Sep 2024 (estimated)
  4. Study completion30 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05940779
Sponsor's protocol ID
H1504602336419
Status last verified
May 2023
First submitted
31 May 2023
Last updated
11 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Therapeutic exercise program in people with Frail Elderly Syndrome and Fall, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Belén Quel Tejón (675760137, bequelte@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timed Up and Go (TUG) (time frame: Assessed before the first intervention (baseline).). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in